Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Ganglioneuroblastoma 3Breast Neoplasms 3Neuroblastoma 2Gliosarcoma 2Glioblastoma 2Wilms Tumor 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Thoracic Diseases 1Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Seroma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pancreatic Neoplasms 1Ovarian Germ Cell Cancer 1Neoplasm Metastasis 1Lymphatic Metastasis 1Lung Neoplasms 1

Interventions

Cetuximab 11Cisplatin 10Radiotherapy 8Docetaxel 8Erlotinib Hydrochloride 7Paclitaxel 6Gemcitabine 6Chemotherapy, Adjuvant 6Immunohistochemistry 5Sorafenib 4Radiosurgery 4Carboplatin 4Capecitabine 4Biopsy 4sargramostim 3Vorinostat 3Trastuzumab 3Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Nivolumab 3N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 3Lapatinib 3Irinotecan 3Filgrastim 3Doxorubicin 3Bevacizumab 3ixabepilone 2aldesleukin 2Taxes 2SS1(dsFv)PE38 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Salivary Gland Neoplasms × Congresses as Topic × Clear all
NCT00470496 2022-07-25

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 1 Completed
15 enrolled
CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡